Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03294551 · ClinicalTrials.gov registry record · NA
HPV Centralized R/R RCT #2 - New York State
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 37,003
- Enrollment target
NCT03294551 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 37,003 participants.
The verdict
NCT03294551, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 37,003 participants
- Enrollment target
Study Summary
The work done in this trial builds off of the work previously conducted by this same research group in clinicaltrials.gov ID: NCT03057379. Due to some changes in study design, protocol, and cohort of interest, a new registration was warranted. The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness, and sustainability of utilizing statewide immunization information systems (IISs) to conduct centralized reminder recall (R/R) to improve human papillomavirus (HPV) vaccination rates among adolescents 11-14 years of age. The latest recommendations from the ACIP, as of February 2017, modified the vaccination schedule for the HPV series for eligible adolescents ages 11-14. Adolescents who receive dose #1 between the ages of 11 and 14 are now eligible for their second and final dose 6-12 months after their initial dose. Despite U.S. guidelines for vaccinating all adolescents starting at age 11 with the HPV vaccine, in 2012 only 53% of 13-17 year old females had \>1 dose and 35% had 3 doses; 21% of teen males had a vaccination. Modeling studies predict marked reduction in HPV associated cancers and in disparities in these cancers if high HPV vaccination rates can be achieved. With this new dosing schedule for adolescents, the research team proposes to conduct a randomized control trial (RCT) utilizing the capabilities of the State Immunization Information System (IIS), and create a HPV-specific R/R autodialer and text message to be delivered to the parents of patients ages 11-14 of randomly selected practices within New York State (excluding NYC). Upon conclusion of this trial, researchers will develop a toolkit for dissemination so that other state IIS systems may replicate these centralized reminder recall procedures.
Interventions
- BEHAVIORAL HPV Vaccine Reminder Recall - Autodialer
- BEHAVIORAL HPV Vaccine Reminder Recall - Texting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37,003 participants |
| Start Date | 2017-10-27 |
| Est. Completion | 2019-11-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03294551
The ClinicalTrials.gov registry entry for NCT03294551 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37,003 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HPV Vaccine Reminder Recall - Autodialer is the first listed.
NCT03294551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03294551 about?
NCT03294551 is a clinical study titled "HPV Centralized R/R RCT #2 - New York State". The work done in this trial builds off of the work previously conducted by this same research group in clinicaltrials.gov ID: NCT03057379. Due to some changes in study design, protocol, and cohort of interest, a new registration was warranted. The overarching goal of this study is to evaluate the e...
What is the current status of trial NCT03294551?
This trial is currently completed. It is a NA study. The enrollment target is 37,003 participants. The study started on 2017-10-27. Estimated completion is 2019-11-05.
What interventions are being tested in trial NCT03294551?
The interventions under investigation include: HPV Vaccine Reminder Recall - Autodialer (BEHAVIORAL), HPV Vaccine Reminder Recall - Texting (BEHAVIORAL).
Who is sponsoring clinical trial NCT03294551?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.